No problem. Of course they couldn't disclose the name of the company but, during the same conversion she did said they are talking with big pharma companies. That was the same term she used right before the Abbott deal was announced. I asked if they had any time restrictions on negotiations with other lincensees as someone suggested on R.B., waiting a couple of months before initiating negotiations with other licensees and she couldn't disclose any specifics regarding their contract with Abbott.
During another conversation she did say it was easier for them to negotiate and pass information between companies since they didn't have all the red tape and buraecacy that larger companies typically have.
I'm sitting on the edge of my seat waiting for the next P.R.. I still believe if we were off the pinks we'd see a higher share price. When the Abbott deal was published the share price went to about $2.35 then stopped almost like it hit a brick wall.
News 
Market Data 
Discover 
